John H Alexander Selected Research

Cardiogenic Shock

1/2020	Association Between Delays in Mechanical Ventilation Initiation and Mortality in Patients With Refractory Cardiogenic Shock.
2/2014	Incidence and outcomes associated with early heart failure pharmacotherapy in patients with ongoing cardiogenic shock.
10/2009	Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery.
5/2007	Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study.
4/2007	Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John H Alexander Research Topics

Disease

113	Atrial Fibrillation 03/2024 - 12/2008
105	Stroke (Strokes) 04/2024 - 04/2005
103	Hemorrhage 05/2024 - 01/2005
71	Myocardial Infarction 04/2024 - 04/2003
54	Acute Coronary Syndrome 01/2022 - 01/2004
41	Embolism (Embolus) 11/2023 - 03/2010
25	Heart Failure 12/2023 - 10/2011
17	Coronary Artery Disease (Coronary Atherosclerosis) 04/2024 - 01/2006
14	Thrombosis (Thrombus) 03/2024 - 01/2005
11	Ischemic Stroke 03/2024 - 03/2010
10	Inflammation (Inflammations) 01/2023 - 04/2007
10	Transient Ischemic Attack 01/2022 - 01/2014
9	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 11/2005
9	Type 2 Diabetes Mellitus (MODY) 01/2024 - 05/2010
9	ST Elevation Myocardial Infarction 11/2018 - 06/2004
8	Left Ventricular Dysfunction 03/2023 - 05/2013
7	COVID-19 05/2024 - 01/2020
7	Ischemia 03/2024 - 12/2004
6	Neoplasms (Cancer) 10/2023 - 01/2011
6	Chronic Renal Insufficiency 01/2023 - 11/2012
6	Venous Thromboembolism 01/2021 - 01/2005
6	Body Weight (Weight, Body) 01/2019 - 04/2005
6	Diabetes Mellitus 01/2019 - 09/2012
5	Hyperplasia 10/2022 - 10/2005
5	Thromboembolism 01/2022 - 01/2005
5	Necrosis 01/2022 - 04/2008
5	Cardiogenic Shock 01/2020 - 04/2007
4	Hypersensitivity (Allergy) 04/2024 - 01/2016
4	Hypoglycemia (Reactive Hypoglycemia) 01/2024 - 01/2012
4	Venous Thrombosis (Deep-Vein Thrombosis) 11/2020 - 01/2005
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2020 - 12/2013
4	Vascular Diseases (Vascular Disease) 01/2019 - 01/2014
4	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2016 - 09/2012
4	Hypertension (High Blood Pressure) 01/2016 - 12/2013
4	Infarction (Infarctions) 10/2009 - 12/2004
3	Coronary Disease (Coronary Heart Disease) 05/2024 - 06/2009
3	Sarcoma (Soft Tissue Sarcoma) 12/2021 - 10/2015
3	Mitral Valve Insufficiency (Mitral Regurgitation) 11/2021 - 01/2012
3	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 01/2019
3	Peripheral Arterial Disease 01/2021 - 01/2016
3	Pulmonary Embolism 11/2020 - 10/2009
3	Kidney Diseases (Kidney Disease) 04/2020 - 01/2018
3	Albuminuria 04/2020 - 01/2018
3	Hemorrhagic Stroke 01/2020 - 09/2011

Drug/Important Bio-Agent (IBA)

101	apixabanIBA 03/2024 - 06/2009
70	Warfarin (Coumadin)FDA LinkGeneric 03/2024 - 03/2010
38	AnticoagulantsIBA 01/2022 - 01/2005
27	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2022 - 06/2008
23	Biomarkers (Surrogate Marker)IBA 03/2024 - 12/2004
19	Vitamin K FDA Link 01/2022 - 03/2010
17	CreatinineIBA 05/2024 - 11/2008
9	Apolipoprotein A-I (Apolipoprotein A1)IBA 04/2024 - 08/2015
9	omega-Chloroacetophenone (Mace)IBA 01/2024 - 06/2013
9	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 11/2014
9	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 06/2004
9	TroponinIBA 01/2020 - 11/2006
9	Factor Xa InhibitorsIBA 01/2020 - 01/2005
8	CSL112IBA 04/2024 - 08/2015
8	LinagliptinIBA 01/2024 - 01/2018
8	Hemoglobins (Hemoglobin)IBA 11/2023 - 10/2014
7	pro-brain natriuretic peptide (1-76)IBA 01/2023 - 04/2016
7	Simendan (Levosimendan)IBA 11/2022 - 12/2016
6	Troponin T (Troponin T1)IBA 01/2022 - 01/2014
6	RB 006IBA 12/2016 - 10/2011
6	Clopidogrel (Plavix)FDA Link 01/2016 - 06/2008
5	fibrin fragment D (D-dimer)IBA 05/2024 - 01/2020
5	Cystatin CIBA 01/2022 - 11/2012
4	CholesterolIBA 04/2024 - 10/2016
4	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2020
4	CalciumIBA 01/2022 - 04/2008
4	Factor Xa (Coagulation Factor Xa)IBA 01/2022 - 01/2005
4	RivaroxabanIBA 01/2022 - 11/2020
4	Interleukin-6 (Interleukin 6)IBA 01/2022 - 04/2016
4	Growth Differentiation Factor 15IBA 11/2021 - 11/2014
4	AlbuminsIBA 01/2021 - 01/2018
4	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2020 - 01/2018
4	Fibrinolytic Agents (Antithrombotic Agents)IBA 05/2017 - 04/2003
4	Troponin IIBA 02/2015 - 11/2006
4	Tenecteplase FDA Link 04/2005 - 04/2003
3	HDL LipoproteinsIBA 04/2024 - 08/2015
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023 - 04/2007
3	Thrombin Receptors (Thrombin Receptor)IBA 01/2022 - 01/2016
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 02/2014
3	Angiotensin Receptor AntagonistsIBA 01/2022 - 02/2014
3	Enoxaparin (Lovenox)FDA LinkGeneric 12/2021 - 06/2004
3	N(4)-oleylcytosine arabinosideIBA 01/2021 - 01/2019
3	Creatine Kinase (Creatine Phosphokinase)IBA 12/2016 - 01/2006
3	MB Form Creatine KinaseIBA 12/2016 - 01/2006
3	Factor IXa (Coagulation Factor IXa)IBA 01/2016 - 06/2008

Therapy/Procedure

71	Therapeutics 03/2024 - 01/2004
31	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 02/2024 - 02/2007
30	Percutaneous Coronary Intervention 02/2024 - 06/2004
7	Stents 03/2024 - 01/2018
7	Cardiopulmonary Bypass (Heart-Lung Bypass) 11/2022 - 04/2008
6	Secondary Prevention 10/2022 - 03/2007
6	Drug Therapy (Chemotherapy) 01/2021 - 02/2014
4	Thrombolytic Therapy 01/2011 - 06/2004
3	Length of Stay 04/2024 - 01/2017
3	Patient Readmission 11/2023 - 09/2012
3	Limb Salvage 12/2021 - 01/2020